Prodiction of molecular subtypes of breast cancer by radiomics based on DCE-MRI

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300070787

Enrollment

Unknown

Registered

2023-04-23

Start date

2023-05-01

Completion date

Unknown

Last updated

2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Gold Standard:Pathological findings

Index test:Preoperative DCE-MRI was performed, and ROC curve was plotted to evaluate the model performance

Eligibility

Sex/Gender

Female

Age

25 Years to 75 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria included: ? Complete imaging and pathological information of tumors; ? No surgery or treatment was done prior to the MRI; ? Complete clinical information.

Exclusion criteria

Exclusion criteria: ?non-mass lesions without delineate boundaries or lesions with longest diameter < 5mm ?incomplete clinical or pathologic characteristics; ?ndergone neoadjuvant chemotherapy, radiation therapy or hormone treatment before MR examination; ?patients with multi-focal lesions or another breast tumor.

Design outcomes

Primary

Measure	Time frame
Receiver operating curve;sensitivity;specificity;accuracy;	—

Countries

China

Contacts

Public ContactMao ning

Yantai Yuhuangding Hospital

maoning@pku.edu.cn+86 13105351972

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026